First-ever clinical data supporting safety and efficacy of in vivo CAR-T Therapy in refractory systemic lupus erythematosus (SLE) patients. Data shows low dose of HN2301 reprogrammed up to 60% of CD8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback